Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced the appointment of Elena Helman, PhD, as Vice President of Oncology Solutions. In this ...
Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, Instruments and Systems and Software), Technology (Sequencing, PCR, Flow Cytometry, ...
Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.
In the fast-changing landscape of the health and wellness sector, businesses require more than generic solutions. They seek platforms that can evolve in accordance with their distinct vision, branding ...
StockStory.org on MSN
10x Genomics (TXG) reports earnings tomorrow: What to expect
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know. 10x Genomics beat analysts’ revenue expectations by 4.6% last ...
The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...
Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...
When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that. Genomics is a key part of the health system’s ...
This article is authored by Ameera Shah, promoter and executive chairperson, Metropolis Healthcare Ltd.
In a country where healthcare often begins after illness strikes, genomics is quietly changing the script. Speaking to Aditi ...
Despite the excitement around AI and advanced analytics, Elie Chaillot stresses that interoperability remains the backbone of ...
Illumina first flagged the deal in June 2025 as part of a strategy to bolt protein readouts onto its sequencing ecosystem, according to Illumina. The seller, Standard BioTools, said it has now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results